Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

202.50p
   
  • Change Today:
      3.90p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 293,327
  • Market Cap: £440.26m
  • RiskGrade: 156

Advanced Medical Solutions appoints Chris Locke as technology chief

By Josh White

Date: Tuesday 27 Jul 2021

LONDON (ShareCast) - (Sharecast News) - Surgical and advanced wound care specialist Advanced Medical Solutions announced on Tuesday that, on 9 August, Chris Locke would join its senior management team as chief technology officer.
The AIM-traded firm said that in the role, he would take full responsibility for all innovation, research, development and technology assessments for the group.

He would be responsible for delivering the increasing pipeline of high-value innovation projects within its expanding portfolio, the board said, as well as identifying external technology opportunities complementary to the business.

"I am delighted to welcome Chris to the senior management team," said chief executive officer Chris Meredith.

"He brings a wealth of experience which will help to drive further process improvement and delivery success from our growing and innovative product portfolio."

Locke was joining AMS from Acelity, having spent 20 years as a senior manager within the $1.6bn global KCI franchise, where he was said to have been "instrumental" in the development, creation and launch of the NPWT therapy range and other wound-care and surgical technologies.

Most recently, he was Acelity's chief innovation officer, and prior to that he held roles as vice-president of research and technology, senior director of global innovation and strategic marketing, and director of engineering, design and technology.

Locke was the named inventor on more than 500 United States patent applications, and 329 granted US patents.

"I am very pleased to be joining AMS," said Chris Locke.

"I look forward to contributing to the company's continued growth as we deliver quality outcomes for patients through innovative surgical and wound care products."

At 1424 BST, shares in Advanced Medical Solutions were down 0.34% at 285.04p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 202.50p
Change Today 3.90p
% Change 1.96 %
52 Week High 258.00
52 Week Low 177.20
Volume 293,327
Shares Issued 217.41m
Market Cap £440.26m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.9% below the market average71.9% below the market average71.9% below the market average71.9% below the market average71.9% below the market average
31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average31.25% above the sector average
Price Trend
40.91% below the market average40.91% below the market average40.91% below the market average40.91% below the market average40.91% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Income
87.17% below the market average87.17% below the market average87.17% below the market average87.17% below the market average87.17% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 09-May-2024

Time Volume / Share Price
16:35 27,342 @ 202.50p
16:35 145 @ 202.50p
16:35 514 @ 202.50p
16:35 245 @ 202.50p
16:35 400 @ 202.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page